Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum

Virology Journal

Volumn 8, Issue , 2011, Pages

  Bhattacharyya, Suchita ^a,b   Hope, Thomas J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; NUCLEOPROTEIN; PROTEIN SUBUNIT; PROTEIN VP40; VIMENTIN; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; MATRIX PROTEIN; VIRUS ENVELOPE PROTEIN; VP40 PROTEIN, VIRUS;

ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL STRAIN HEK293; CYTOTOXICITY; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; ENDOPLASMIC RETICULUM; ENDOSOME; GOLGI COMPLEX; HUMAN; HUMAN CELL; MARBURG HEMORRHAGIC FEVER; MARBURG VIRUS; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSIENT TRANSFECTION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS NUCLEOCAPSID; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN TRANSPORT;

EBOLA VIRUS; FILOVIRIDAE; LAKE VICTORIA MARBURGVIRUS;

EBOLAVIRUS; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, VIRAL; GLYCOPROTEINS; HEK293 CELLS; HUMANS; NUCLEAR ENVELOPE; NUCLEOPROTEINS; PROTEIN TRANSPORT; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS;

EID: 78651243915     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-11     Document Type: Article

References (43)

1. A system for functional analysis of Ebola virus glycoprotein. A Takada C Robison H Goto A Sanchez KG Murti MA Whitt Y Kawaoka, Proc Natl Acad Sci USA 1997 94 14764 14769 10.1073/pnas.94.26.14764 9405687
2. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. RJ Wool-Lewis P Bates, J Virol 1998 72 3155 3160 9525641
3. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. SY Chan MC Ma MA Goldsmith, J Gen Virol 2000 81 2155 2159 10950971
4. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. G Simmons RJ Wool-Lewis F Baribaud RC Netter P Bates, J Virol 2002 76 2518 2528 10.1128/jvi.76.5.2518-2528.2002 11836430
5. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. A Takada S Watanabe H Ito K Okazaki H Kida Y Kawaoka, Virology 2000 278 20 26 10.1006/viro.2000.0601 11112476
6. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. VM Wahl-Jensen TA Afanasieva J Seebach U Stroher H Feldmann HJ Schnittler, J Virol 2005 79 10442 10450 10.1128/JVI.79.16.10442-10450.2005 16051836
7. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. V Wahl-Jensen SK Kurz PR Hazelton HJ Schnittler U Stroher DR Burton H Feldmann, J Virol 2005 79 2413 2419 10.1128/JVI.79.4. 2413-2419.2005 15681442
8. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. ZY Yang HJ Duckers NJ Sullivan A Sanchez EG Nabel GJ Nabel, Nat Med 2000 6 886 889 10.1038/78645 10932225
9. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. N Alazard-Dany V Volchkova O Reynard C Carbonnelle O Dolnik M Ottmann A Khromykh VE Volchkov, J Gen Virol 2006 87 1247 1257 10.1099/vir.0.81361-0 16603527
10. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. K Steele B Crise A Kuehne W Kell, Arch Pathol Lab Med 2001 125 625 630 11300932
11. Release of viral glycoproteins during Ebola virus infection. VE Volchkov VA Volchkova W Slenczka HD Klenk H Feldmann, Virology 1998 245 110 119 10.1006/viro.1998.9143 9614872
12. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. VE Volchkov VA Volchkova E Muhlberger LV Kolesnikova M Weik O Dolnik HD Klenk, Science 2001 291 1965 1969 10.1126/science.1057269 11239157
13. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. T Noda H Sagara E Suzuki A Takada H Kida Y Kawaoka, J Virol 2002 76 4855 4865 10.1128/JVI.76.10.4855-4865.2002 11967302
14. Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. JM Licata RF Johnson Z Han RN Harty, J Virol 2004 78 7344 7351 10.1128/JVI.78.14.7344-7351.2004 15220407
15. Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. RF Johnson P Bell RN Harty, Virol J 2006 3 31 10.1186/1743-422X-3-31 16719918
16. Molecular biology and evolution of filoviruses. H Feldmann HD Klenk A Sanchez, Arch Virol Suppl 1993 7 81 100 8219816
17. Nedd4 regulates egress of Ebola virus-like particles from host cells. J Yasuda M Nakao Y Kawaoka H Shida, J Virol 2003 77 9987 9992 10.1128/JVI.77.18. 9987-9992.2003 12941909
18. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. J Martin-Serrano T Zang PD Bieniasz, Nat Med 2001 7 1313 1319 10.1038/nm1201-1313 11726971
19. Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. S Yamayoshi T Noda H Ebihara H Goto Y Morikawa IS Lukashevich G Neumann H Feldmann Y Kawaoka, Cell Host Microbe 2008 3 168 177 10.1016/j.chom.2008.02.001 18329616
20. VP40 octamers are essential for Ebola virus replication. T Hoenen V Volchkov L Kolesnikova E Mittler J Timmins M Ottmann O Reynard S Becker W Weissenhorn, J Virol 2005 79 1898 1905 10.1128/JVI.79.3.1898-1905.2005 15650213
21. The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. A Sanchez MP Kiley BP Holloway JB McCormick DD Auperin, Virology 1989 170 81 91 10.1016/0042-6822(89)90354-1 2718390
22. Descriptive analysis of Ebola virus proteins. LH Elliott MP Kiley JB McCormick, Virology 1985 147 169 176 10.1016/0042-6822(85)90236-3 4060597
23. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. NJ Sullivan M Peterson ZY Yang WP Kong H Duckers E Nabel GJ Nabel, J Virol 2005 79 547 553 10.1128/JVI.79.1.547-553.2005 15596847
24. Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. JR Francica MK Matukonis P Bates, Virology 2009 383 237 247 10.1016/j.virol.2008.10.029 19013626
25. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. SR Bartz MA Vodicka, Methods 1997 12 337 342 10.1006/meth.1997.0487 9245614
26. Context-dependent effects of L domains and ubiquitination on viral budding. J Martin-Serrano D Perez-Caballero PD Bieniasz, J Virol 2004 78 5554 5563 10.1128/JVI.78.11.5554-5563.2004 15140952
27. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. KL Warfield DL Swenson GG Olinger WV Kalina MJ Aman S Bavari, J Infect Dis 2007 196 Suppl 2 430 437 10.1086/520583 17940980
28. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. S Bhattacharyya KL Warfield G Ruthel S Bavari MJ Aman TJ Hope, Virology 2010 401 18 28 10.1016/j.virol.2010.02.015 20202662
29. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. RG Panchal G Ruthel TA Kenny GH Kallstrom D Lane SS Badie L Li S Bavari MJ Aman, Proc Natl Acad Sci USA 2003 100 15936 15941 10.1073/pnas.2533915100 14673115
30. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. JM Licata M Simpson-Holley NT Wright Z Han J Paragas RN Harty, J Virol 2003 77 1812 1819 10.1128/JVI.77.3.1812-1819.2003 12525615
31. Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding. SE McCarthy RF Johnson YA Zhang JO Sunyer RN Harty, J Virol 2007 81 11452 11460 10.1128/JVI.00853-07 17699576
32. Aggresomes, inclusion bodies and protein aggregation. RR Kopito, Trends Cell Biol 2000 10 524 530 10.1016/S0962-8924(00)01852-3 11121744
33. Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. L Kolesnikova E Muhlberger E Ryabchikova S Becker, J Virol 2000 74 3899 3904 10.1128/JVI.74.8.3899-3904.2000 10729166
34. Interactions of Marburg virus nucleocapsid proteins. S Becker C Rinne U Hofsass HD Klenk E Muhlberger, Virology 1998 249 406 417 10.1006/viro.1998.9328 9791031
35. Aggresomes resemble sites specialized for virus assembly. CM Heath M Windsor T Wileman, J Cell Biol 2001 153 449 455 10.1083/jcb.153.3.449 11331297
36. Formation of aggresome-like structures in herpes simplex virus type 2-infected cells and a potential role in virus assembly. N Nozawa Y Yamauchi K Ohtsuka Y Kawaguchi Y Nishiyama, Exp Cell Res 2004 299 486 497 10.1016/j.yexcr.2004.06.010 15350546
37. Packaging of actin into Ebola virus VLPs. Z Han RN Harty, Virol J 2005 2 92 10.1186/1743-422X-2-92 16367999
38. Classification, structure, and replication of filoviruses. H Feldmann MP Kiley, Curr Top Microbiol Immunol 1999 235 1 21 9893375
39. Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain. O Martinez C Valmas CF Basler, Virology 2007 364 342 354 10.1016/j.virol.2007.03. 020 17434557
40. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. CA Zampieri JF Fortin GP Nolan GJ Nabel, J Virol 2007 81 1230 1240 10.1128/JVI.01586-06 17108034
41. Classic swine fever virus NS2 protein leads to the induction of cell cycle arrest at S-phase and endoplasmic reticulum stress. QH Tang YM Zhang L Fan G Tong L He C Dai, Virol J 2010 7 4 10.1186/1743-422X-7-4 20064240
42. The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. R Minakshi K Padhan M Rani N Khan F Ahmad S Jameel, PLoS One 2009 4 8342 10.1371/journal.pone.0008342 20020050
43. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. T Kobayashi MH Beuchat M Lindsay S Frias RD Palmiter H Sakuraba RG Parton J Gruenberg, Nat Cell Biol 1999 1 113 118 10.1038/15666 10559883